DRONCIT- praziquantel injection, solution

País: Estados Unidos

Idioma: inglés

Fuente: NLM (National Library of Medicine)

Cómpralo ahora

Ficha técnica Ficha técnica (SPC)
02-12-2020

Ingredientes activos:

PRAZIQUANTEL (UNII: 6490C9U457) (PRAZIQUANTEL - UNII:6490C9U457)

Disponible desde:

Bayer HealthCare LLC Animal Health Division

Designación común internacional (DCI):

PRAZIQUANTEL

Composición:

PRAZIQUANTEL 56.8 mg in 1 mL

Vía de administración:

INTRAMUSCULAR

tipo de receta:

PRESCRIPTION

indicaciones terapéuticas:

Droncit (praziquantel) Injectable Cestocide is indicated for the removal of the following canine and/or feline cestodes. Dogs: Dipylidium caninum, Taenia pisiformis, Echinococcus granulosus and for the removal and control of Echinococcus multilocularis . Cats: Taenia taeniaeformis and Dipylidium caninum . There are no known contraindications to the use of praziquantel.

Resumen del producto:

10 mL vial 50 mL vial Store at or below 25ºC.  Do not allow to freeze.

Estado de Autorización:

New Animal Drug Application

Ficha técnica

                                DRONCIT- PRAZIQUANTEL INJECTION, SOLUTION
BAYER HEALTHCARE LLC ANIMAL HEALTH DIVISION
----------
DRONCIT
(PRAZIQUANTEL)
INJECTABLE CESTOCIDE
FOR DOGS AND CATS
56.8 mg/mL Solution
CAUTION:
Federal (U.S.A.) law restricts this drug to use by or on the order of
a licensed veterinarian.
DESCRIPTION:
Droncit Injectable Cestocide is a clear solution containing 56.8
milligrams of praziquantel per mL
which has been formulated for subcutaneous or intramuscular use in
dogs and cats for removal of
cestodes (tapeworms).
INDICATIONS:
Droncit (praziquantel) Injectable Cestocide is indicated for the
removal of the following canine and/or
feline cestodes. Dogs: _Dipylidium caninum, Taenia pisiformis,
Echinococcus granulosus _and for the
removal and control of _Echinococcus multilocularis_. Cats: _Taenia
taeniaeformis_ and _Dipylidium caninum_.
ACTION:
Droncit (praziquantel) is absorbed, metabolized in the liver and
excreted via the bile into the digestive
tract where its cestocidal activity is exerted.
Following exposure to praziquantel, the tapeworm loses
its ability to resist digestion by the mammalian host. Because of
this, whole tapeworms, including the
scolex, are very rarely passed after administration of praziquantel.
It is common to see only
disintegrated and partially digested pieces of tapeworms in the stool.
The majority of tapeworms killed
are digested and are not found in the feces.
USE DIRECTIONS:
Droncit (praziquantel) Injectable Cestocide may be administered by
either the subcutaneous or
intramuscular route to dogs and cats. The recommended dosage of
praziquantel varies according to
body weight. Smaller animals require a relatively larger dosage. The
optimum dosage for each
individual animal will be achieved by utilizing the following dosage
schedule.
DOGS AND PUPPIES†
Dogs:
5 lbs. and under 0.3 mL
6-10 lbs. 0.5 mL
11-25 lbs. 1.0 mL
over 25 lbs. 0.2 mL /5 lbs.
body weight to a
maximum of 3 mL
®
1
† Not intended for use in puppies less than four (4) weeks of age.
CATS AND KITTENS††
Cats:
Under 5 lbs. 0.2 m
                                
                                Leer el documento completo
                                
                            

Buscar alertas relacionadas con este producto